Fondaparinux is a synthetic pentasaccharide anticoagulant belonging to the heparinoid class, primarily indicated for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism. This category… Read more







Fondaparinux is a synthetic pentasaccharide anticoagulant belonging to the heparinoid class, primarily indicated for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism. This category provides essential reference standards, including the active pharmaceutical ingredient, diverse impurities, and stable isotope labelled compounds required for rigorous pharmaceutical analysis. Laboratories utilize these materials for critical tasks such as impurity profiling, method validation, and establishing system suitability to ensure analytical accuracy. Because of the complex molecular structure of this anticoagulant, accessing precise standards is necessary for quantifying trace components and verifying therapeutic consistency. These materials support quality control workflows, allowing researchers to maintain strict compliance with regulatory standards throughout the development and manufacturing lifecycle of the drug.